Clinical Evaluation of Efficacy of Ã¢â?¬Å?Rasnadi GugguluÃ¢â?¬? , Ã¢â?¬Å?Rasnadashamooladi KwathaÃ¢â?¬? and Ã¢â?¬Å?Griva VastiÃ¢â?¬? in the Management of Griva-Sandhigata Vata (Cervical Spondylosis)

ational Institute of Ayurveda0 个研究点目标入组 0 人开始时间: 待定最近更新: 2022年10月17日

试验速览

暂无简介。

•1.Patients willing to signature the consent form for the clinical trial.
•2.Patients of either sex.
•3. Patients above 20 years and less than 70 years.
•4. Clinical symptoms of Ã¢â?¬Ë?Griva-Sandhigata VataÃ¢â?¬• (Cervical Spondylosis) with or without radiological changes.

•1.Stenosis of spinal cord
•2.Contraindication and allergy to any drug in Rasnadi Guggulu, Rasnadashamooladi Kwatha or Dashamooladi Taila used for Griva Vasti.
•3.Recent cervical, spinal, or shoulder surgery or implanted instrumentation or previous surgery for cervical spondylotic myelopathy.
•4.Myofacial pain
•5.Patients suffering from any infectious disease (like tuberculosis), metabolic disease (like diabetes mellitus and hypothyroidism), chronicdisease (like rheumatoid arthritis, SLE, ankylosing spondylitis).
•6.Pregnant and lactating mothers.

发起方